Humulin_R: profile and news

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
Diabetes Care Products In the fourth quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and recently launched Byetta ... - PR Newswire (press release),

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
In the fourth quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R), Actos(R) and recently launched Byetta, increased 11 percent ... - Finanzen.net,

Generex Biotechnology Presents Oral Insulin Clinical Data At The ... Sep 14, 2005
Data shows that Oral-lyn(TM) and Humulin(R)R induced similar glucodynamic responses TORONTO, Sept. 14 /PRNewswire-FirstCall/ -- Generex ... - PR Newswire (press release),

Generex Biotechnology Presents Oral Insulin Clinical Data At The ... Sep 14, 2005
...its proprietary oral insulin spray product, made a presentation of Oral-lyn(TM) clinical trial results titled "A 12-Day Comparison of Preprandial Humulin(R)R vs ... - PharmaLive.com (press release),

Generex Biotechnology Presents Clinical Trial Results at ... Oct 4, 2005
Aguirre, Marco Guevara and Jeannette Saavedra of the Institute of Endocrinology IEMYR in Quito, Ecuador; -- "A 12-Day Comparison of Preprandial Humulin(R) vs. ... - PR Newswire (press release),

Generex Biotechnology Presents Clinical Trial Results at ... Oct 4, 2005
Diabetes Mellitus (DM)", a study coauthored by Dr. Jaime Guevara-. -- "A 12-Day Comparison of Preprandial Humulin(R) vs. Oral-lyn(TM) in 10. ... - PharmaLive.com (press release),

Generex Biotechnology Presents Clinical Trial Results at ... Oct 4, 2005
Institute of Endocrinology IEMYR in Quito, Ecuador; -- "A 12-Day Comparison of Preprandial Humulin(R) vs. Oral-lyn(TM) in 10 Type ... - Biotech Intelligence (press release),

Generex Biotechnology Clinician To Present Clinical Trial Results ... Sep 20, 2005
...and the Lawson Wilkins Pediatric Endocrine Society to be held in Lyon, France from September 21 - 24, 2005: * "A 12-Day Comparison of Preprandial Humulin(R) vs ... - PR Newswire (press release),

Generex Biotechnology Clinician To Present Clinical Trial Results ... Sep 20, 2005
...* "A 12-Day Comparison of Preprandial Humulin(R) vs. Oral-lyn(TM) in 10. scheduled for poster presentation on September 22, 2005. The study is. ... - PharmaLive.com (press release),

Lilly's Withdrawal of Human Insulin Has Veterinary Ramifications ... 08 Sep 2005
In July 2005, Lilly announced it is discontinuing four insulin products -- Humulin(R) L Lente(R), Humulin(R) U Ultralente(R), regular Iletin(R) II and NPH ... - Genetic Engineering News,

Generex Biotechnology Clinician to Present Clinical Trial Results ... Sep 7, 2005
Greece from September 10-15, 2005. The presentation, titled "A 12-Day Comparison of Preprandial Humulin(R) vs. Oral-lyn(TM) in 10 ... - PR Newswire (press release),

Information Regarding Insulin Storage and Switching Sep 3, 2005
One brand of regular insulin (eg Humulin R, Novolin R) may be substituted for another brand of regular insulin and for rapid-acting insulins (eg, Humalog ... - Community Dispatch (press release)

Generex Biotechnology Presents Clinical Trial Results at the ... Jul 6, 2005
Generex clinician Dr. Jaime Guevara-Aguirre made an oral presentation of a study entitled "A 12-Day Comparison of Preprandial Humulin(R) regular insulin vs. ... - PharmaLive.com (press release) <**results**>

Generex Biotechnology Presents Oral-lyn(TM) Clinical Trial Results Jun 14, 2005
GD) profiles induced by single pre-prandial versus pre- and post-prandial split doses of Oral-lyn(TM) were compared to the GD profile of Humulin-R in a 3-day ... - PR Newswire (press release)

ADA: A Patch for Insulin Delivery May Be Option for Diabetics Jun 14, 2005
Dr. Heinemann and colleagues applied patches containing 150 U of Humulin R U-500 (human insulin) to the radio-frequency treated forearms of five healthy ... - MedPage Today,

Care of diabetic inmates faulted Apr 26, 2005
Lassiter testified that the jail also administered rapid and long-acting insulin, Humulin-R and Humulin-L, to deal with short- and long-term issues. ... - AL.com

Lilly Reports $.68 Earnings Per Share in the First Quarter Apr 18, 2005
Diabetes Care Products In the first quarter of 2005, diabetes care revenue, composed primarily of Humalog(R), Humulin(R) and Actos(R), increased 6 percent, to ... - PR Newswire